- The Daily Trade
- Posts
- Market Insights: Nucor's Earnings Drop, AstraZeneca's Investigation, and Fed's Rate Cut Signals 📉
Market Insights: Nucor's Earnings Drop, AstraZeneca's Investigation, and Fed's Rate Cut Signals 📉
Ryan Serkes
December 17, 2024
In partnership with
The Daily Trade delivers sharp, daily insights on the US stock market.
Stay informed, spot trends, and trade with confidence.
We put your money to work
Betterment’s financial experts and automated investing technology are working behind the scenes to make your money hustle while you do whatever you want.
Recent Headlines
Technical Analysis Results
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
CVS Health's Caremark, Cigna's Express Scripts and UnitedHealth Group's Optum control the majority of the U.S. pharmacy benefit market, with their parent companies also operating health insurance and pharmacy businesses.Pharmacy benefit managers negotiate drug costs with pharmacies and drug manufacturers and help build drug coverage lists for health plans, mostly on behalf of employers and the government.
Johnson & Johnson (JNJ) is suing Cigna's divisions, Express Scripts and Accredo, claiming they worke
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
Morning Brief co-hosts Seana Smith and Brad Smith break down the latest stock calls on Wall Street. Goldman Sachs analysts has tapped Uber (UBER) as its top stock pick for 2025, with analyst Eric Sheridan highlighting the company's compelling risk-reward profile. Sheridan believes Uber has significant upside potential, driven by its advertising business. Similarly, Morgan Stanley's team has named Apple (AAPL) as a top pick for the coming year, citing artificial intelligence as a key catalyst for an iPhone upgrade cycle. The firm anticipates AI will fuel growth in both sales and gross margins for the tech giant. Meanwhile, JPMorgan has initiated a broad downgrade of homebuilder stocks, including DR Horton (DHI), Toll Brothers (TOL), and Meritage Homes Corp. (MTH). The firm cited a less favorable demand and supply landscape heading into 2025. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Angel Smith
The latest trading day saw D.R. Horton (DHI) settling at $151.21, representing a -1.61% change from its previous close.
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
Steel Dynamics warned that lower prices and shipments and an unplanned outage at a factory will affect current-quarter earnings.
Steel Dynamics, Inc. (NASDAQ/GS: STLD) today provided fourth quarter 2024 earnings guidance in the range of $1.26 to $1.30 per diluted share. Comparatively, the company's sequential third quarter 2024 earnings were $2.05 per diluted share, and prior year fourth quarter earnings were $2.61 per diluted share.
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
HOUSTON, December 10, 2024--Westlake Corporation (NYSE: WLK) today announced that Mr. Roger A. Cregg has been appointed to the company’s board of directors. Mr. Cregg succeeds Mr. Marius A. Haas who, as previously disclosed, informed the board that he intended to retire from the board effective upon the appointment of his successor. Mr. Haas’ retirement from the board was effective on December 10, 2024.
Westlake (WLK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
It might be of some concern to shareholders to see the FTAI Aviation Ltd. ( NASDAQ:FTAI ) share price down 16% in the...
Shares of aircraft leasing company FTAI Aviation (NASDAQ:FTAI) fell 8.2% in the afternoon session after Reuters reported that Boeing is planning to increase the production of its 787 Dreamliner Jets to 10 planes per month by 2026, which likely means fewer engagements for parts suppliers, including FTAI.
RSI Sell | MFI Sell | WillR Sell | AO Sell |
CCI Sell | BBANDS Sell | ULTOSC Sell | STOCH Sell |
Blue Owl Capital shares a spot on IBD Leaderboard with Nvidia, Meta and Google. But only Owl stock pulls off this stock-list trifecta.
2024 has been "one big valuation surprise" that has been "dominated by the [Magnificent] Seven megacap growth cohort," Citi head of US equity strategy Scott Chonert tells Julie Hyman and Josh Lipton on Market Domination. The strategist says not only does the Magnificent Seven group, made up of Nvidia (NVDA), Alphabet (GOOG, GOOGL), Tesla (TSLA), Microsoft (MSFT), Amazon (AMZN), Meta Platforms (META), and Apple (AAPL), has more room to run in 2025, the stocks could actually function as a defensive play amid market uncertainty. "We're thinking the Mag Seven actually unfold as a quasi staple," Chronert says, explaining, "Usually you go to [consumer] staples when you have uncertain economic conditions because of the persistence of earnings growth." "The Mag Seven, we think, that forward-looking earnings growth for certainly for [2025] and probably into [2026] is fairly visible. So all told, when you get concerned about other things at work in the market and the economy, the Mag Seven actually have this potential to be a quote, defensive if you will." The strategist highlights the phrase "growth is defensive," saying, "That's what's going on here." He notes, "These companies probably can't just live on meeting expectations. They need to continue to meet beat and then probably raise forward expectations as well" to maintain their "defensive" status. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.
We want to hear from YOU!
Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.
Simply reply to this email with your thoughts. Every comment helps us serve you better.
Thank you for being a valued reader.
How would you rate today's newsletter?If there's anything I can do better, please let me know so I can make improvements! |
Technical Indicator Information
Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30
Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20
Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80
Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75
Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal
Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20
Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100
Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band
Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price
Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0
Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30
Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI
Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25
Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.
Disclaimers
The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.
Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.
The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.